Anti-PD-L1 Antibody Drug Combo May Improve Outcomes in Advanced Kidney Cancer
Anti–PD-L1 monoclonal antibody benmelstobart plus anlotinib for the frontline treatment of advanced renal cell carcinoma (RCC), a type of kidney ...
Tag: first-line treatment
FDA Approves Sarclisa In Newly Diagnosed Transplant-Ineligible Multiple Myeloma
Sarclisa, a new drug, has been approved by the FDA for treating newly diagnosed, transplant-ineligible multiple myeloma patients, demonstrating a ...
First-Line Rybrevant Plus Lazcluze Shows Trend Toward Overall Survival in EGFR-Positive NSCLC
First-Line Rybrevant Plus Lazcluze Shows Trend Toward Overall Survival in EGFR-Positive NSCLCIn the first line of treatment, Rybrevant (amivantamab) plus ...